The store will not work correctly when cookies are disabled.
1-(3,4-dihydroquinolin-1(2H)-yl)-2-(1-phenylethylamino)ethanone
ID: ALA4475187
PubChem CID: 54815068
Max Phase: Preclinical
Molecular Formula: C19H22N2O
Molecular Weight: 294.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(NCC(=O)N1CCCc2ccccc21)c1ccccc1
Standard InChI: InChI=1S/C19H22N2O/c1-15(16-8-3-2-4-9-16)20-14-19(22)21-13-7-11-17-10-5-6-12-18(17)21/h2-6,8-10,12,15,20H,7,11,13-14H2,1H3
Standard InChI Key: MUNKDGJCJYOMFJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
28.3279 -5.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3267 -6.0487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0348 -6.4577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7444 -6.0482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7416 -5.2256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0330 -4.8203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0306 -4.0031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7370 -3.5924 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3216 -3.5966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4460 -3.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1524 -3.5882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8614 -3.9947 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1500 -2.7710 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.2720 -4.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2715 -3.9899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5621 -3.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5631 -5.2152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8617 -4.8077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1601 -5.2113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1588 -6.0223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8649 -6.4280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5635 -6.0220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
7 9 1 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 18 1 0
12 16 1 0
17 14 1 0
14 15 1 0
15 16 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.40 | Molecular Weight (Monoisotopic): 294.1732 | AlogP: 3.32 | #Rotatable Bonds: 4 |
Polar Surface Area: 32.34 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.03 | CX LogP: 3.21 | CX LogD: 2.49 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.94 | Np Likeness Score: -1.30 |
References
1. Vázquez-Villa H, Trabanco AA.. (2019) Progress toward allosteric ligands of metabotropic glutamate 7 (mGlu7) receptor: 2008-present., 10 (2): [PMID:30881607] [10.1039/C8MD00524A] |